Abstract
The deposition of cholesterol in the arterial wall by the infiltration of low-density lipoproteins (LDLs) is a key step in the development of atherosclerosis. In this Commentary, we discuss recent recommendations for clinical laboratory measurement of low-density lipoprotein cholesterol (LDL-C) and its utility both for assessing cardiovascular disease risk and as a tool in the management of patients receiving lipid-lowering therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 20-22 |
Number of pages | 3 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 96 |
Issue number | 1 |
DOIs | |
State | Published - 2014 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)